Literature DB >> 22615380

CCAAT/enhancer-binding protein δ facilitates bacterial dissemination during pneumococcal pneumonia in a platelet-activating factor receptor-dependent manner.

Janwillem Duitman1, Marcel Schouten, Angelique P Groot, Keren S Borensztajn, Joost B Daalhuisen, Sandrine Florquin, Tom van der Poll, C Arnold Spek.   

Abstract

CCAAT/enhancer-binding protein δ (C/EBPδ) recently emerged as an essential player in the inflammatory response to bacterial infections. C/EBPδ levels increase rapidly after a proinflammatory stimulus, and increasing C/EBPδ levels seem to be indispensable for amplification of the inflammatory response. Here we aimed to elucidate the role of C/EBPδ in host defense in community-acquired pneumococcal pneumonia. We show that C/EBPδ(-/-) mice are relatively resistant to pneumococcal pneumonia, as indicated by delayed and reduced mortality, diminished outgrowth of pneumococci in lungs, and reduced dissemination of the infection. Moreover, expression of platelet-activating factor receptor (PAFR), which is known to potentiate bacterial translocation of gram-positive bacteria, was significantly reduced during infection in C/EBPδ(-/-) mice compared with WT controls. Importantly, cell stimulation experiments revealed that C/EBPδ potentiates PAFR expression induced by lipoteichoic acid and pneumococci. Thus, C/EBPδ exaggerates bacterial dissemination during Streptococcus pneumoniae-induced pulmonary infection, suggesting an important role for PAFR-dependent bacterial translocation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22615380      PMCID: PMC3384171          DOI: 10.1073/pnas.1202641109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America.

Authors:  J G Bartlett; S F Dowell; L A Mandell; T M File; D M Musher; M J Fine
Journal:  Clin Infect Dis       Date:  2000-09-07       Impact factor: 9.079

2.  Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia.

Authors:  Anita W Rijneveld; Marcel Levi; Sandrine Florquin; Peter Speelman; Peter Carmeliet; Tom van Der Poll
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

3.  Efficacy and safety of recombinant human activated protein C for severe sepsis.

Authors:  G R Bernard; J L Vincent; P F Laterre; S P LaRosa; J F Dhainaut; A Lopez-Rodriguez; J S Steingrub; G E Garber; J D Helterbrand; E W Ely; C J Fisher
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

4.  The C/EBP bZIP domain can mediate lipopolysaccharide induction of the proinflammatory cytokines interleukin-6 and monocyte chemoattractant protein-1.

Authors:  H M Hu; Q Tian; M Baer; C J Spooner; S C Williams; P F Johnson; R C Schwartz
Journal:  J Biol Chem       Date:  2000-05-26       Impact factor: 5.157

5.  Hedgehog signaling maintains chemoresistance in myeloid leukemic cells.

Authors:  K C S Queiroz; R R Ruela-de-Sousa; G M Fuhler; H L Aberson; C V Ferreira; M P Peppelenbosch; C A Spek
Journal:  Oncogene       Date:  2010-08-30       Impact factor: 9.867

6.  Janus kinase 2 activation by the platelet-activating factor receptor (PAFR): roles of Tyk2 and PAFR C terminus.

Authors:  Viktoria Lukashova; Zhangguo Chen; Roy J Duhé; Marek Rola-Pleszczynski; Jana Stanková
Journal:  J Immunol       Date:  2003-10-01       Impact factor: 5.422

7.  Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response.

Authors:  T Alam; M R An; J Papaconstantinou
Journal:  J Biol Chem       Date:  1992-03-15       Impact factor: 5.157

8.  Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice.

Authors:  Anita W Rijneveld; Sebastiaan Weijer; Sandrine Florquin; Peter Speelman; Takao Shimizu; Satosh Ishii; Tom van der Poll
Journal:  J Infect Dis       Date:  2004-01-30       Impact factor: 5.226

9.  Participation of the transcription factor C/EBP delta in the acute-phase regulation of the human gene for complement component C3.

Authors:  T S Juan; D R Wilson; M D Wilde; G J Darlington
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

Review 10.  Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.

Authors:  Charles Feldman
Journal:  J Lab Clin Med       Date:  2004-05
View more
  16 in total

1.  A1 adenosine receptor signaling reduces Streptococcus pneumoniae adherence to pulmonary epithelial cells by targeting expression of platelet-activating factor receptor.

Authors:  Manmeet Bhalla; Jun Hui Yeoh; Claire Lamneck; Sydney E Herring; Essi Y I Tchalla; Lauren R Heinzinger; John M Leong; Elsa N Bou Ghanem
Journal:  Cell Microbiol       Date:  2019-11-20       Impact factor: 3.715

2.  Dabigatran potentiates gemcitabine-induced growth inhibition of pancreatic cancer in mice.

Authors:  Kun Shi; Helene Damhofer; Joost Daalhuisen; Marieke Ten Brink; Dick J Richel; C Arnold Spek
Journal:  Mol Med       Date:  2017-02-06       Impact factor: 6.354

3.  Protease activated receptor-1 deficiency diminishes bleomycin-induced skin fibrosis.

Authors:  JanWillem Duitman; Roberta R Ruela-de-Sousa; Kun Shi; Onno J de Boer; Keren S Borensztajn; Sandrine Florquin; Maikel P Peppelenbosch; C Arnold Spek
Journal:  Mol Med       Date:  2014-09-18       Impact factor: 6.354

Review 4.  Pseudomonas aeruginosa: breaking down barriers.

Authors:  Bryan J Berube; Stephanie M Rangel; Alan R Hauser
Journal:  Curr Genet       Date:  2015-09-25       Impact factor: 3.886

5.  Activation of platelet-activating factor receptor exacerbates renal inflammation and promotes fibrosis.

Authors:  Matheus Correa-Costa; Vinicius Andrade-Oliveira; Tarcio T Braga; Angela Castoldi; Cristhiane F Aguiar; Clarice S T Origassa; Andrea C D Rodas; Meire I Hiyane; Denise M A C Malheiros; Francisco J O Rios; Sonia Jancar; Niels O S Câmara
Journal:  Lab Invest       Date:  2014-02-03       Impact factor: 5.662

6.  CCAAT-enhancer binding protein delta (C/EBPδ) attenuates tubular injury and tubulointerstitial fibrogenesis during chronic obstructive nephropathy.

Authors:  JanWillem Duitman; Keren S Borensztajn; Willem P C Pulskens; Jaklien C Leemans; Sandrine Florquin; C Arnold Spek
Journal:  Lab Invest       Date:  2013-11-18       Impact factor: 5.662

7.  Exposure to welding fumes and lower airway infection with Streptococcus pneumoniae.

Authors:  Reetika Suri; Jimstan Periselneris; Sophie Lanone; Patti C Zeidler-Erdely; Geoffrey Melton; Keith T Palmer; Pascal Andujar; James M Antonini; Vanessa Cohignac; Aaron Erdely; Ricardo J Jose; Ian Mudway; Jeremy Brown; Jonathan Grigg
Journal:  J Allergy Clin Immunol       Date:  2015-08-12       Impact factor: 10.793

8.  Biological roles of CCAAT/Enhancer-binding protein delta during inflammation.

Authors:  Chiung-Yuan Ko; Wen-Chang Chang; Ju-Ming Wang
Journal:  J Biomed Sci       Date:  2015-01-16       Impact factor: 8.410

9.  Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis.

Authors:  Cong Lin; Jan von der Thüsen; Joost Daalhuisen; Marieke ten Brink; Bruno Crestani; Tom van der Poll; Keren Borensztajn; C Arnold Spek
Journal:  J Cell Mol Med       Date:  2015-02-16       Impact factor: 5.310

10.  Bronchial Epithelial Tet2 Maintains Epithelial Integrity during Acute Pseudomonas aeruginosa Pneumonia.

Authors:  Wanhai Qin; Xanthe Brands; Cornelis Van't Veer; Alex F de Vos; Brendon P Scicluna; Tom van der Poll
Journal:  Infect Immun       Date:  2020-12-15       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.